Emtricitabine, lopinavir, ritonavir, and tenofovir and Ranibizumab
Determining the interaction of Emtricitabine, lopinavir, ritonavir, and tenofovir and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine, lopinavir, ritonavir, and tenofovir-Ranibizumab Intraocular
- Emtricitabine, lopinavir, ritonavir, and tenofovir-Ranibizumab ophthalmic
- Emtricitabine, lopinavir, ritonavir, and tenofovir-Ranitidine
- Emtricitabine, lopinavir, ritonavir, and tenofovir-Ranitidine Capsule
- Emtricitabine, lopinavir, ritonavir, and tenofovir-Ranitidine Hydrochloride
- Emtricitabine, lopinavir, ritonavir, and tenofovir-Ranitidine Injection
- Ranibizumab-Emtricitabine, nelfinavir, and tenofovir
- Ranibizumab-Emtricitabine, rilpivirine, and tenofovir
- Ranibizumab-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Ranibizumab-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Ranibizumab-Emtriva
- Ranibizumab-Emtriva (Emtricitabine Capsules)